Jilin Tianlitai Pharmaceutical

Jilin Tianlitai Pharmaceutical is a comprehensive pharmaceutical manufacturing company based in Meihekou City, Jilin Province, China. Established in 2003, the company specializes in the research, development, and production of both chemical drugs and traditional Chinese medicine (TCM) preparations. Its commercial portfolio features widely recognized treatments for respiratory ailments, such as Keganmin (Compound Paracetamol and Amantadine Hydrochloride), as well as herbal extracts like Ginkgo Biloba for cardiovascular health. Operating with modern, GMP-certified facilities, the company focuses on the modernization of traditional therapies through advanced extraction and solid dosage formulation technologies. Jilin Tianlitai primarily serves the domestic Chinese healthcare market and is recognized as a key industrial enterprise in its region.